Current position
Education
- 2024: PhD in Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University
- 2019: Doctor of Pharmacy degree in Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University
- 2018: Master's degree in Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University
Teaching activities
Experience abroad
- Utrecht University, Faculty of Science, Division of Pharmacoepidemiology & Clinical Pharmacology
- Utrecht Summer School in Pharmacoepidemiology and Drug Safety (4 – 8 July 2022)
- 5-month ERASMUS+ traineeship (May–Sep 2022)
- supervisor: Dr. Daniala L. Weir
- Sorbonne University, Faculty of Medicine (4EU+ Alliance)
- integrated 4EU+ Pharmacoepidemiology educational course (March–April 2022)
Professional membership
- European Society of Clinical Pharmacy (ESCP)
- Czech Pharmaceutical Society – Section of Clinical Pharmacy
- Czech Chamber of Pharmacists
Grant projects
- OP JAK (Johannes Amos Comenius Programme)
- project BIPOLE - WP6: Personalized Pharmacotherapy
- team member: junior researcher
- Canadian Institutes of Health Research (CIHR)
- networking event: Individual Patient Data Meta-Analysis on Adverse Drug Events Across the Continuum of Care
- grant for a networking event at Utrecht University in 2025
- Charles University Grant Agency
Publications
PubMed list
Juhásová Z, Karapinar-Çarkit F, Weir DL. The use of International Classification of Diseases codes to identify hospital admissions linked with adverse drug events: validation study. British Journal of Clinical Pharmacology. 2025; doi: 10.1002/BCP.70116 (accepted)
Očovská Z, Procházková J, Maříková M, Vlček J. Renal drug dosage adjustments and adverse drug events in patients with chronic kidney disease admitted to the hospital: A cross-sectional study. Expert Opin Drug Saf. 2024; 23(4):457-467. doi: 10.1080/14740338.2023.2295980
Očovská Z, Maříková M, Vlček J. Potentially Clinically Significant Drug-Drug Interactions in Older Patients Admitted to the Hospital: A Cross-sectional Study. Front Pharmacol. 2023;14:1088900. doi: 10.3389/fphar.2023.1088900
Očovská Z, Maříková M, Kočí J, Vlček J. Drug-related Hospital Admissions via the Department of Emergency Medicine: A Cross-sectional Study from the Czech Republic. Front Pharmacol. 2022; 13: 899151. doi: 10.3389/fphar.2022.899151
Maříková M, Očovská Z, Nerad V, Kuběna AA, Blaha V, Vlček J. Hospital admissions to geriatric ward related to adverse drug events: a cross-sectional study from the Czech Republic. Int J Clin Pharm. 2021;43(5):1218-1226. doi: 10.1007/s11096-021-01237-y
International collaboration
- Dr. Daniala L. Weir (Utrecht University)
- Dr. Fatma Karapinar (Maastricht University)
Research interests
- Pharmacoepidemiology:
- epidemiologic characteristics of adverse drug events that lead to hospitalization
- the potential of using routinely collected data to detect adverse drug events that lead to hospitalization
- Drug Safety and Pharmacovigilance:
- causality assessment of adverse drug reactions identified in post-marketing period
- proposing strategies to detect adverse drug reactions that result in hospitalizations
- Drug Information:
- comparison of drug-information sources to detect and address various drug-related problems (e.g. drug-drug interactions, drug dosing in renal impairment)
- Health services and outcomes research
- identification and risk minimization of drug-related problems